Share Price and Basic Stock Data
Last Updated: January 27, 2026, 9:05 pm
| PEG Ratio | -1.07 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Meghmani Organics Ltd operates within the agrochemicals sector, specifically focusing on pesticides. As of the latest reporting, the company’s market capitalization stood at ₹1,440 Cr, with a share price of ₹56.5. Revenue from operations for the trailing twelve months (TTM) was reported at ₹2,313 Cr, showing a decline from ₹2,553 Cr in FY 2023. Quarterly sales reflected a fluctuating trend, with the latest quarter ending September 2023 recording sales of ₹379 Cr, down from ₹646 Cr in September 2022. This downward trajectory in revenue raises concerns about the company’s growth sustainability, particularly as it faces competitive pressures in the agrochemical market, where typical sector growth rates are often higher. The company’s operating profit margin (OPM) has also been under pressure, standing at just 9%, which is lower than many of its peers in the sector.
Profitability and Efficiency Metrics
Meghmani’s profitability has exhibited considerable volatility, with net profit for the trailing twelve months reported at ₹40 Cr. In contrast, the company recorded a net profit of ₹238 Cr in FY 2023, indicating a significant deterioration in earnings. The operating profit for the most recent quarter, September 2023, was a mere ₹8 Cr, leading to an OPM of only 2%. This decline in profitability is compounded by rising expenses, which have consistently outpaced revenue growth. The interest coverage ratio (ICR) stood at 2.70x, suggesting that while the company can meet its interest obligations, it operates within a narrow margin. The cash conversion cycle (CCC) of 113 days indicates inefficiencies in inventory and receivables management, which may further hinder profitability and operational efficiency.
Balance Sheet Strength and Financial Ratios
The balance sheet of Meghmani Organics reflects a mixed picture of financial health. Total assets reached ₹3,285 Cr, with total liabilities at ₹3,085 Cr, resulting in a debt-to-equity ratio of 0.54x. This level of leverage is relatively moderate; however, the company reported borrowings of ₹841 Cr, which could pose risks if cash flows do not stabilize. Reserves stood at ₹1,514 Cr, providing a buffer against potential downturns. The return on equity (ROE) was reported at 0.80%, which is considerably low, indicating that shareholder returns are not being maximized. Additionally, the price-to-book value (P/BV) ratio of 1.03x is marginally above the sector average, suggesting that the stock may be fairly valued in the context of its book value, but investor confidence might wane due to low profitability ratios.
Shareholding Pattern and Investor Confidence
Meghmani’s shareholding structure reveals a significant level of promoter ownership at 48.98%, alongside public holding at 49.50%. Foreign institutional investors (FIIs) held 1.48% of the company, reflecting limited foreign interest, while domestic institutional investors (DIIs) had no stake. The number of shareholders increased to 1,31,853, indicating growing public interest. However, the stability of the share price and investor confidence may be undermined by the declining profitability trends and inconsistent revenue performance. The promoter holding has remained relatively stable, which could be interpreted as a vote of confidence from insiders, but the lack of institutional backing may limit price support during downturns. As the company navigates through challenging market conditions, investor sentiment will be crucial for maintaining share price stability.
Outlook, Risks, and Final Insight
The outlook for Meghmani Organics is contingent upon its ability to stabilize revenues and improve operational efficiency. The company faces significant risks, including fluctuating raw material costs and competitive pressures from larger players in the agrochemical space. Additionally, the reported decline in profitability raises concerns about cash flow sustainability, which could impact future growth initiatives. However, if the company can effectively manage its costs and improve its operational metrics, it may regain investor confidence. The potential for strategic partnerships or new product developments could also enhance growth prospects. Ultimately, while the current financials present challenges, a focused approach to cost management and innovation could provide a pathway for recovery and growth in the competitive agrochemical sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Epigral Ltd | 4,555 Cr. | 1,056 | 2,114/1,045 | 11.3 | 487 | 0.57 % | 24.9 % | 22.3 % | 10.0 |
| Dharmaj Crop Guard Ltd | 730 Cr. | 216 | 391/165 | 15.0 | 131 | 0.00 % | 12.0 % | 9.28 % | 10.0 |
| Bhaskar Agrochemicals Ltd | 54.4 Cr. | 104 | 149/56.6 | 9.75 | 40.0 | 0.00 % | 21.3 % | 24.7 % | 10.0 |
| Bhagiradha Chemicals & Industries Ltd | 2,604 Cr. | 203 | 331/198 | 98.3 | 54.9 | 0.07 % | 7.44 % | 4.91 % | 1.00 |
| Best Agrolife Ltd | 775 Cr. | 22.0 | 35.8/16.3 | 60.6 | 22.8 | 0.91 % | 12.9 % | 9.95 % | 1.00 |
| Industry Average | 10,322.45 Cr | 1,043.38 | 28.82 | 369.04 | 0.46% | 15.21% | 19.87% | 6.67 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 646 | 549 | 574 | 426 | 379 | 352 | 410 | 414 | 544 | 569 | 553 | 614 | 577 |
| Expenses | 567 | 497 | 496 | 448 | 371 | 360 | 408 | 408 | 513 | 528 | 488 | 547 | 525 |
| Operating Profit | 78 | 53 | 78 | -22 | 8 | -8 | 2 | 6 | 31 | 41 | 65 | 67 | 52 |
| OPM % | 12% | 10% | 14% | -5% | 2% | -2% | 0% | 1% | 6% | 7% | 12% | 11% | 9% |
| Other Income | 26 | 24 | 27 | 7 | 12 | 10 | 9 | 9 | 12 | 9 | 14 | 17 | 28 |
| Interest | -3 | 43 | 16 | 4 | 13 | 27 | 2 | 11 | 26 | 13 | 19 | 29 | 24 |
| Depreciation | 18 | 18 | 23 | 24 | 23 | 23 | 23 | 23 | 25 | 30 | 29 | 30 | 30 |
| Profit before tax | 89 | 15 | 67 | -43 | -16 | -48 | -14 | -19 | -9 | 7 | 31 | 24 | 26 |
| Tax % | 25% | 46% | 19% | -20% | -3% | -20% | 25% | -13% | 1% | 159% | 35% | 48% | 56% |
| Net Profit | 66 | 8 | 54 | -34 | -15 | -38 | -18 | -17 | -9 | -4 | 20 | 13 | 12 |
| EPS in Rs | 2.60 | 0.33 | 2.13 | -1.36 | -0.60 | -1.50 | -0.71 | -0.66 | -0.36 | -0.17 | 0.78 | 0.50 | 0.45 |
Last Updated: December 30, 2025, 12:07 am
Below is a detailed analysis of the quarterly data for Meghmani Organics Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 577.00 Cr.. The value appears to be declining and may need further review. It has decreased from 614.00 Cr. (Jun 2025) to 577.00 Cr., marking a decrease of 37.00 Cr..
- For Expenses, as of Sep 2025, the value is 525.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 547.00 Cr. (Jun 2025) to 525.00 Cr., marking a decrease of 22.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 52.00 Cr.. The value appears to be declining and may need further review. It has decreased from 67.00 Cr. (Jun 2025) to 52.00 Cr., marking a decrease of 15.00 Cr..
- For OPM %, as of Sep 2025, the value is 9.00%. The value appears to be declining and may need further review. It has decreased from 11.00% (Jun 2025) to 9.00%, marking a decrease of 2.00%.
- For Other Income, as of Sep 2025, the value is 28.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Jun 2025) to 28.00 Cr., marking an increase of 11.00 Cr..
- For Interest, as of Sep 2025, the value is 24.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 29.00 Cr. (Jun 2025) to 24.00 Cr., marking a decrease of 5.00 Cr..
- For Depreciation, as of Sep 2025, the value is 30.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 30.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 26.00 Cr.. The value appears strong and on an upward trend. It has increased from 24.00 Cr. (Jun 2025) to 26.00 Cr., marking an increase of 2.00 Cr..
- For Tax %, as of Sep 2025, the value is 56.00%. The value appears to be increasing, which may not be favorable. It has increased from 48.00% (Jun 2025) to 56.00%, marking an increase of 8.00%.
- For Net Profit, as of Sep 2025, the value is 12.00 Cr.. The value appears to be declining and may need further review. It has decreased from 13.00 Cr. (Jun 2025) to 12.00 Cr., marking a decrease of 1.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.45. The value appears to be declining and may need further review. It has decreased from 0.50 (Jun 2025) to 0.45, marking a decrease of 0.05.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:59 am
| Metric | Mar 2020n n 6m | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 700 | 1,637 | 2,498 | 2,553 | 1,566 | 2,080 | 2,313 |
| Expenses | 595 | 1,353 | 2,119 | 2,211 | 1,586 | 1,936 | 2,088 |
| Operating Profit | 105 | 283 | 379 | 342 | -19 | 144 | 225 |
| OPM % | 15% | 17% | 15% | 13% | -1% | 7% | 10% |
| Other Income | 130 | 30 | 102 | 114 | 37 | 42 | 67 |
| Interest | 18 | 11 | 9 | 66 | 46 | 69 | 85 |
| Depreciation | 22 | 51 | 63 | 77 | 92 | 108 | 119 |
| Profit before tax | 194 | 252 | 409 | 313 | -121 | 9 | 88 |
| Tax % | 23% | 26% | 26% | 24% | -12% | 212% | |
| Net Profit | 150 | 186 | 304 | 238 | -106 | -11 | 40 |
| EPS in Rs | 29,914.00 | 37,296.00 | 11.97 | 9.35 | -4.17 | -0.42 | 1.56 |
| Dividend Payout % | 17% | 19% | 12% | 15% | -0% | -0% |
YoY Net Profit Growth
| Year | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|
| YoY Net Profit Growth (%) | 63.44% | -21.71% | -144.54% | 89.62% |
| Change in YoY Net Profit Growth (%) | 0.00% | -85.15% | -122.83% | 234.16% |
Meghmani Organics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 4 years from 2021-2022 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 24% |
| 3 Years: | -6% |
| TTM: | 47% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 121% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -13% |
| 1 Year: | -25% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 8% |
| 3 Years: | 2% |
| Last Year: | -1% |
Last Updated: Unknown
Balance Sheet
Last Updated: December 4, 2025, 1:38 am
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
| Reserves | 961 | 1,148 | 1,441 | 1,644 | 1,502 | 1,490 | 1,514 |
| Borrowings | 264 | 268 | 499 | 824 | 837 | 829 | 841 |
| Other Liabilities | 407 | 533 | 832 | 705 | 674 | 741 | 905 |
| Total Liabilities | 1,657 | 1,974 | 2,798 | 3,198 | 3,039 | 3,085 | 3,285 |
| Fixed Assets | 481 | 634 | 911 | 1,166 | 1,152 | 1,575 | 1,540 |
| CWIP | 101 | 112 | 188 | 356 | 521 | 83 | 80 |
| Investments | 191 | 304 | 211 | 183 | 114 | 3 | 3 |
| Other Assets | 885 | 924 | 1,487 | 1,494 | 1,251 | 1,425 | 1,662 |
| Total Assets | 1,657 | 1,974 | 2,798 | 3,198 | 3,039 | 3,085 | 3,285 |
Below is a detailed analysis of the balance sheet data for Meghmani Organics Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,514.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,490.00 Cr. (Mar 2025) to 1,514.00 Cr., marking an increase of 24.00 Cr..
- For Borrowings, as of Sep 2025, the value is 841.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 829.00 Cr. (Mar 2025) to 841.00 Cr., marking an increase of 12.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 905.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 741.00 Cr. (Mar 2025) to 905.00 Cr., marking an increase of 164.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,285.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,085.00 Cr. (Mar 2025) to 3,285.00 Cr., marking an increase of 200.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,540.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,575.00 Cr. (Mar 2025) to 1,540.00 Cr., marking a decrease of 35.00 Cr..
- For CWIP, as of Sep 2025, the value is 80.00 Cr.. The value appears to be declining and may need further review. It has decreased from 83.00 Cr. (Mar 2025) to 80.00 Cr., marking a decrease of 3.00 Cr..
- For Investments, as of Sep 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,662.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,425.00 Cr. (Mar 2025) to 1,662.00 Cr., marking an increase of 237.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,285.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,085.00 Cr. (Mar 2025) to 3,285.00 Cr., marking an increase of 200.00 Cr..
Notably, the Reserves (1,514.00 Cr.) exceed the Borrowings (841.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2020n n 6m | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Free Cash Flow | 105.00 | 15.00 | -120.00 | -482.00 | -856.00 | -685.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Debtor Days | 241 | 92 | 79 | 75 | 101 | 99 |
| Inventory Days | 271 | 152 | 161 | 158 | 185 | 173 |
| Days Payable | 209 | 137 | 144 | 108 | 176 | 159 |
| Cash Conversion Cycle | 302 | 106 | 96 | 124 | 110 | 113 |
| Working Capital Days | 152 | 89 | 57 | 53 | 26 | 20 |
| ROCE % | 19% | 24% | 16% | -3% | 3% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Motilal Oswal Nifty Microcap 250 Index Fund | 140,745 | 0.19 | 1.06 | 140,745 | 2025-04-22 05:19:08 | 0% |
| Groww Nifty Total Market Index Fund | 369 | 0.01 | 0 | 369 | 2025-04-22 17:25:26 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | -0.42 | -4.17 | 9.35 | 11.97 | 7.33 |
| Diluted EPS (Rs.) | -0.42 | -4.17 | 9.35 | 11.97 | 7.33 |
| Cash EPS (Rs.) | 3.83 | -0.54 | 12.38 | 14.43 | 9.33 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 59.58 | 60.07 | 65.64 | 57.65 | 46.13 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 59.58 | 60.07 | 65.64 | 57.65 | 46.13 |
| Revenue From Operations / Share (Rs.) | 81.78 | 61.59 | 100.37 | 98.24 | 64.36 |
| PBDIT / Share (Rs.) | 7.34 | 0.68 | 17.19 | 18.67 | 12.08 |
| PBIT / Share (Rs.) | 3.09 | -2.94 | 14.16 | 16.20 | 10.09 |
| PBT / Share (Rs.) | 0.37 | -4.76 | 12.31 | 16.07 | 9.90 |
| Net Profit / Share (Rs.) | -0.41 | -4.17 | 9.35 | 11.97 | 7.33 |
| NP After MI And SOA / Share (Rs.) | -0.41 | -4.17 | 9.35 | 11.97 | 7.33 |
| PBDIT Margin (%) | 8.97 | 1.11 | 17.12 | 19.00 | 18.76 |
| PBIT Margin (%) | 3.77 | -4.77 | 14.10 | 16.49 | 15.67 |
| PBT Margin (%) | 0.45 | -7.73 | 12.26 | 16.36 | 15.38 |
| Net Profit Margin (%) | -0.50 | -6.76 | 9.31 | 12.18 | 11.39 |
| NP After MI And SOA Margin (%) | -0.50 | -6.76 | 9.31 | 12.18 | 11.39 |
| Return on Networth / Equity (%) | -0.69 | -6.94 | 14.24 | 20.76 | 15.89 |
| Return on Capital Employeed (%) | 4.17 | -3.77 | 16.60 | 23.37 | 18.85 |
| Return On Assets (%) | -0.34 | -3.48 | 7.43 | 10.88 | 9.44 |
| Long Term Debt / Equity (X) | 0.18 | 0.25 | 0.24 | 0.14 | 0.10 |
| Total Debt / Equity (X) | 0.54 | 0.54 | 0.49 | 0.33 | 0.18 |
| Asset Turnover Ratio (%) | 0.67 | 0.50 | 0.85 | 1.06 | 0.89 |
| Current Ratio (X) | 1.12 | 1.15 | 1.42 | 1.39 | 1.62 |
| Quick Ratio (X) | 0.62 | 0.65 | 0.79 | 0.77 | 1.01 |
| Inventory Turnover Ratio (X) | 3.73 | 1.55 | 2.35 | 3.18 | 2.81 |
| Dividend Payout Ratio (NP) (%) | 0.00 | -33.58 | 14.97 | 11.69 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | -257.96 | 11.31 | 9.69 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 133.58 | 85.03 | 88.31 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 357.96 | 88.69 | 90.31 | 0.00 |
| Interest Coverage Ratio (X) | 2.70 | 0.37 | 6.65 | 50.45 | 27.44 |
| Interest Coverage Ratio (Post Tax) (X) | 0.84 | -1.29 | 4.33 | 32.70 | 17.08 |
| Enterprise Value (Cr.) | 2357.58 | 2831.39 | 2761.81 | 3135.90 | 0.00 |
| EV / Net Operating Revenue (X) | 1.13 | 1.81 | 1.08 | 1.26 | 0.00 |
| EV / EBITDA (X) | 12.63 | 162.66 | 6.32 | 6.61 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 0.74 | 1.29 | 0.77 | 1.06 | 0.00 |
| Retention Ratios (%) | 0.00 | 133.58 | 85.02 | 88.30 | 0.00 |
| Price / BV (X) | 1.03 | 1.32 | 1.18 | 1.81 | 0.00 |
| Price / Net Operating Revenue (X) | 0.74 | 1.29 | 0.77 | 1.06 | 0.00 |
| EarningsYield | -0.01 | -0.05 | 0.12 | 0.11 | 0.00 |
After reviewing the key financial ratios for Meghmani Organics Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.42. This value is below the healthy minimum of 5. It has increased from -4.17 (Mar 24) to -0.42, marking an increase of 3.75.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.42. This value is below the healthy minimum of 5. It has increased from -4.17 (Mar 24) to -0.42, marking an increase of 3.75.
- For Cash EPS (Rs.), as of Mar 25, the value is 3.83. This value is within the healthy range. It has increased from -0.54 (Mar 24) to 3.83, marking an increase of 4.37.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 59.58. It has decreased from 60.07 (Mar 24) to 59.58, marking a decrease of 0.49.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 59.58. It has decreased from 60.07 (Mar 24) to 59.58, marking a decrease of 0.49.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 81.78. It has increased from 61.59 (Mar 24) to 81.78, marking an increase of 20.19.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 7.34. This value is within the healthy range. It has increased from 0.68 (Mar 24) to 7.34, marking an increase of 6.66.
- For PBIT / Share (Rs.), as of Mar 25, the value is 3.09. This value is within the healthy range. It has increased from -2.94 (Mar 24) to 3.09, marking an increase of 6.03.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.37. This value is within the healthy range. It has increased from -4.76 (Mar 24) to 0.37, marking an increase of 5.13.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -0.41. This value is below the healthy minimum of 2. It has increased from -4.17 (Mar 24) to -0.41, marking an increase of 3.76.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -0.41. This value is below the healthy minimum of 2. It has increased from -4.17 (Mar 24) to -0.41, marking an increase of 3.76.
- For PBDIT Margin (%), as of Mar 25, the value is 8.97. This value is below the healthy minimum of 10. It has increased from 1.11 (Mar 24) to 8.97, marking an increase of 7.86.
- For PBIT Margin (%), as of Mar 25, the value is 3.77. This value is below the healthy minimum of 10. It has increased from -4.77 (Mar 24) to 3.77, marking an increase of 8.54.
- For PBT Margin (%), as of Mar 25, the value is 0.45. This value is below the healthy minimum of 10. It has increased from -7.73 (Mar 24) to 0.45, marking an increase of 8.18.
- For Net Profit Margin (%), as of Mar 25, the value is -0.50. This value is below the healthy minimum of 5. It has increased from -6.76 (Mar 24) to -0.50, marking an increase of 6.26.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -0.50. This value is below the healthy minimum of 8. It has increased from -6.76 (Mar 24) to -0.50, marking an increase of 6.26.
- For Return on Networth / Equity (%), as of Mar 25, the value is -0.69. This value is below the healthy minimum of 15. It has increased from -6.94 (Mar 24) to -0.69, marking an increase of 6.25.
- For Return on Capital Employeed (%), as of Mar 25, the value is 4.17. This value is below the healthy minimum of 10. It has increased from -3.77 (Mar 24) to 4.17, marking an increase of 7.94.
- For Return On Assets (%), as of Mar 25, the value is -0.34. This value is below the healthy minimum of 5. It has increased from -3.48 (Mar 24) to -0.34, marking an increase of 3.14.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 0.2. It has decreased from 0.25 (Mar 24) to 0.18, marking a decrease of 0.07.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.54. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.54.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.67. It has increased from 0.50 (Mar 24) to 0.67, marking an increase of 0.17.
- For Current Ratio (X), as of Mar 25, the value is 1.12. This value is below the healthy minimum of 1.5. It has decreased from 1.15 (Mar 24) to 1.12, marking a decrease of 0.03.
- For Quick Ratio (X), as of Mar 25, the value is 0.62. This value is below the healthy minimum of 1. It has decreased from 0.65 (Mar 24) to 0.62, marking a decrease of 0.03.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.73. This value is below the healthy minimum of 4. It has increased from 1.55 (Mar 24) to 3.73, marking an increase of 2.18.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -33.58 (Mar 24) to 0.00, marking an increase of 33.58.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -257.96 (Mar 24) to 0.00, marking an increase of 257.96.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 133.58 (Mar 24) to 0.00, marking a decrease of 133.58.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 357.96 (Mar 24) to 0.00, marking a decrease of 357.96.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.70. This value is below the healthy minimum of 3. It has increased from 0.37 (Mar 24) to 2.70, marking an increase of 2.33.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 3. It has increased from -1.29 (Mar 24) to 0.84, marking an increase of 2.13.
- For Enterprise Value (Cr.), as of Mar 25, the value is 2,357.58. It has decreased from 2,831.39 (Mar 24) to 2,357.58, marking a decrease of 473.81.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.13. This value is within the healthy range. It has decreased from 1.81 (Mar 24) to 1.13, marking a decrease of 0.68.
- For EV / EBITDA (X), as of Mar 25, the value is 12.63. This value is within the healthy range. It has decreased from 162.66 (Mar 24) to 12.63, marking a decrease of 150.03.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has decreased from 1.29 (Mar 24) to 0.74, marking a decrease of 0.55.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 133.58 (Mar 24) to 0.00, marking a decrease of 133.58.
- For Price / BV (X), as of Mar 25, the value is 1.03. This value is within the healthy range. It has decreased from 1.32 (Mar 24) to 1.03, marking a decrease of 0.29.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has decreased from 1.29 (Mar 24) to 0.74, marking a decrease of 0.55.
- For EarningsYield, as of Mar 25, the value is -0.01. This value is below the healthy minimum of 5. It has increased from -0.05 (Mar 24) to -0.01, marking an increase of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Meghmani Organics Ltd:
- Net Profit Margin: -0.5%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 4.17% (Industry Average ROCE: 15.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -0.69% (Industry Average ROE: 19.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.84
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.62
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 35.8 (Industry average Stock P/E: 28.82)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.54
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -0.5%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agro Chemicals/Pesticides | 1st to 3rd Floor, Near Raj Bunglow, Ahmedabad Gujarat 380015 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ankit Patel | Chairman & Managing Director |
| Mr. Karana Patel | Executive Director |
| Mr. Darshan Patel | Executive Director |
| Mr. Maulik Patel | Non Executive Director |
| Mr. Kaushal Soparkar | Non Executive Director |
| Ms. Urvashi D Shah | Independent Director |
| Mr. Manubhai K Patel | Independent Director |
| Prof. (Dr) Ganapati Yadav | Independent Director |
| Dr. Varesh Govindprasad Sinha | Independent Director |
| Mr. Nikunt Raval | Independent Director |
FAQ
What is the intrinsic value of Meghmani Organics Ltd?
Meghmani Organics Ltd's intrinsic value (as of 27 January 2026) is ₹9.42 which is 83.12% lower the current market price of ₹55.80, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,418 Cr. market cap, FY2025-2026 high/low of ₹106/55.0, reserves of ₹1,514 Cr, and liabilities of ₹3,285 Cr.
What is the Market Cap of Meghmani Organics Ltd?
The Market Cap of Meghmani Organics Ltd is 1,418 Cr..
What is the current Stock Price of Meghmani Organics Ltd as on 27 January 2026?
The current stock price of Meghmani Organics Ltd as on 27 January 2026 is ₹55.8.
What is the High / Low of Meghmani Organics Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Meghmani Organics Ltd stocks is ₹106/55.0.
What is the Stock P/E of Meghmani Organics Ltd?
The Stock P/E of Meghmani Organics Ltd is 35.8.
What is the Book Value of Meghmani Organics Ltd?
The Book Value of Meghmani Organics Ltd is 60.6.
What is the Dividend Yield of Meghmani Organics Ltd?
The Dividend Yield of Meghmani Organics Ltd is 0.00 %.
What is the ROCE of Meghmani Organics Ltd?
The ROCE of Meghmani Organics Ltd is 3.39 %.
What is the ROE of Meghmani Organics Ltd?
The ROE of Meghmani Organics Ltd is 0.80 %.
What is the Face Value of Meghmani Organics Ltd?
The Face Value of Meghmani Organics Ltd is 1.00.